Style | Citing Format |
---|---|
MLA | Yazdanian N, Mozafarpoor S, Goodarzi A. "Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review." Dermatologic Therapy, vol. 34, no. 1, 2021, pp. -. |
APA | Yazdanian N, Mozafarpoor S, Goodarzi A (2021). Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review. Dermatologic Therapy, 34(1), -. |
Chicago | Yazdanian N, Mozafarpoor S, Goodarzi A. "Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review." Dermatologic Therapy 34, no. 1 (2021): -. |
Harvard | Yazdanian N, Mozafarpoor S, Goodarzi A (2021) 'Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review', Dermatologic Therapy, 34(1), pp. -. |
Vancouver | Yazdanian N, Mozafarpoor S, Goodarzi A. Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review. Dermatologic Therapy. 2021;34(1):-. |
BibTex | @article{ author = {Yazdanian N and Mozafarpoor S and Goodarzi A}, title = {Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review}, journal = {Dermatologic Therapy}, volume = {34}, number = {1}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Yazdanian N AU - Mozafarpoor S AU - Goodarzi A TI - Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review JO - Dermatologic Therapy VL - 34 IS - 1 SP - EP - PY - 2021 ER - |